Hung-Sheng Hua , Yi-Ting Huang , Hong-Sheng Lee , Chia-Hao Liu , Wei Chao , Bing-Chang Chen , Chien-Huang Lin
{"title":"Role of C/EBPβ/STAT3/AP-1 transcriptional complex formation in thrombin-induced connective tissue growth factor expression in human lung fibroblasts","authors":"Hung-Sheng Hua , Yi-Ting Huang , Hong-Sheng Lee , Chia-Hao Liu , Wei Chao , Bing-Chang Chen , Chien-Huang Lin","doi":"10.1016/j.ejphar.2025.178178","DOIUrl":null,"url":null,"abstract":"<div><div>CCAAT/enhancer-binding protein-β (C/EBPβ) may play a key role in idiopathic pulmonary fibrosis progression. Despite this, the mechanism through which the formation of the transcriptional complex comprising C/EBPβ, signal transducer and activator of transcription 3 (STAT3), and activator protein-1 (AP-1) impacts the regulation of connective tissue growth factor (CTGF) production by thrombin in human lung fibroblasts (WI-38) is not well understood. In this study, C/EBPβ knockdown suppressed thrombin-stimulated CTGF production and CTGF-luciferase activity. The phosphorylation and cytosol-to-nucleus translocation of C/EBPβ were enhanced by thrombin. C/EBPβ knockdown attenuated thrombin-induced STAT3-and AP-1-luciferase activity. Upon thrombin stimulation, the C/EBPβ/STAT3/AP-1 complex was bound to the CTGF promoter. Both the phosphatidylinositol 3-kinase (PI3K) inhibitor and the dominant negative mutant of Akt inhibited thrombin-stimulated CTGF production, C/EBPβ phosphorylation, and C/EBPβ-luciferase activity. Furthermore, co-inhibition of the Akt, c-Jun N-terminal kinase (JNK), and Janus kinase 2 (JAK2) did not further reduce thrombin-induced C/EBPβ-luciferase activity compared to inhibition of each pathway alone. In bleomycin-induced pulmonary fibrosis, the phosphorylation of C/EBPβ, STAT3, and c-Jun in lung tissue was higher than the control group. In addition, the protein levels of C/EBPβ and CTGF, but not of c-Jun and STAT3, were higher than those in the control group. In conclusion, thrombin activates the PI3K/Akt pathway to activate C/EBPβ, which in turn induces CTGF expression in human lung fibroblasts. C/EBPβ/STAT3/AP-1 transcriptional complex formation plays an essential role in thrombin-triggered CTGF production. C/EBPβ upregulation and C/EBPβ/STAT3/AP-1 complex formation may play crucial roles in lung fibrosis and have potential for use as therapeutic targets.</div></div>","PeriodicalId":12004,"journal":{"name":"European journal of pharmacology","volume":"1006 ","pages":"Article 178178"},"PeriodicalIF":4.7000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S001429992500932X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
CCAAT/enhancer-binding protein-β (C/EBPβ) may play a key role in idiopathic pulmonary fibrosis progression. Despite this, the mechanism through which the formation of the transcriptional complex comprising C/EBPβ, signal transducer and activator of transcription 3 (STAT3), and activator protein-1 (AP-1) impacts the regulation of connective tissue growth factor (CTGF) production by thrombin in human lung fibroblasts (WI-38) is not well understood. In this study, C/EBPβ knockdown suppressed thrombin-stimulated CTGF production and CTGF-luciferase activity. The phosphorylation and cytosol-to-nucleus translocation of C/EBPβ were enhanced by thrombin. C/EBPβ knockdown attenuated thrombin-induced STAT3-and AP-1-luciferase activity. Upon thrombin stimulation, the C/EBPβ/STAT3/AP-1 complex was bound to the CTGF promoter. Both the phosphatidylinositol 3-kinase (PI3K) inhibitor and the dominant negative mutant of Akt inhibited thrombin-stimulated CTGF production, C/EBPβ phosphorylation, and C/EBPβ-luciferase activity. Furthermore, co-inhibition of the Akt, c-Jun N-terminal kinase (JNK), and Janus kinase 2 (JAK2) did not further reduce thrombin-induced C/EBPβ-luciferase activity compared to inhibition of each pathway alone. In bleomycin-induced pulmonary fibrosis, the phosphorylation of C/EBPβ, STAT3, and c-Jun in lung tissue was higher than the control group. In addition, the protein levels of C/EBPβ and CTGF, but not of c-Jun and STAT3, were higher than those in the control group. In conclusion, thrombin activates the PI3K/Akt pathway to activate C/EBPβ, which in turn induces CTGF expression in human lung fibroblasts. C/EBPβ/STAT3/AP-1 transcriptional complex formation plays an essential role in thrombin-triggered CTGF production. C/EBPβ upregulation and C/EBPβ/STAT3/AP-1 complex formation may play crucial roles in lung fibrosis and have potential for use as therapeutic targets.
期刊介绍:
The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems.
The scope includes:
Behavioural pharmacology
Neuropharmacology and analgesia
Cardiovascular pharmacology
Pulmonary, gastrointestinal and urogenital pharmacology
Endocrine pharmacology
Immunopharmacology and inflammation
Molecular and cellular pharmacology
Regenerative pharmacology
Biologicals and biotherapeutics
Translational pharmacology
Nutriceutical pharmacology.